Position
Chief Financial Officer
Company
Jupiter Endovascular
Menlo ParkBiotechnologyHealth Caremedical devicesDescription
Jupiter Endovascular, Inc. announced the appointment of Fred Ong as Chief Financial Officer. Fred Ong brings over 30 years of experience in building and growing venture capital-backed healthcare technology companies to his new role at Jupiter Endovascular, including playing key roles in fundraising, corporate strategy, operational growth, revenue scale, and M&A exits.
Quick answer
Jupiter Endovascular Appoints Fred Ong as Chief Financial Officer (February 27, 2025). Jupiter Endovascular is based in Menlo Park, California, United States.
- Who is the new Chief Financial Officer at Jupiter Endovascular?
- Jupiter Endovascular named Fred Ong Chief Financial Officer, announced February 27, 2025.
- What did Jupiter Endovascular announce on February 27, 2025?
- Jupiter Endovascular, Inc. announced the appointment of Fred Ong as Chief Financial Officer. Fred Ong brings over 30 years of experience in building and growing venture capital-backed healthcare technology companies to his new role at Jupiter Endovascular, including playing key roles in fundraising, corporate strategy, operational growth, revenue scale, and M&A exits.
- What does Jupiter Endovascular do?
- Jupiter Endovascular is a medical technology startup developing the “endoportal procedure,” a new class of endovascular interventions using Endoportal Control to bring the precision and control of direct surgical access...
- Where is Jupiter Endovascular based?
- Jupiter Endovascular is based in Menlo Park, California, United States.
- Which similar companies made leadership changes around the same time?
- CMR Surgical (January 26, 2025), FoRx Therapeutics (February 26, 2025), Supernus, Inc. (February 27, 2025) and Minnetronix Medical (February 27, 2025) also announced leadership changes within 45 days of Jupiter Endovascular.
Source: Fundz verified event record.
Other recent leadership changes in medical devices and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- CMR Surgical Appoints Massimiliano Colella as CEO (January 26, 2025)
- FoRx Therapeutics Appoints Jens Würthner as Chief Medical Officer (February 26, 2025)
- Indivior Names Joe Ciaffoni as Chief Executive Officer, Mark Crossley to Step Down (February 27, 2025)
- Minnetronix Medical Appoints Nicole Jung as CFO (February 27, 2025)
- Ondine Biomedical Appoints Michael S. Behlke as CFO and COO (February 26, 2025)
- ViCentra Appoints Tom Arnold as Chief Executive Officer (February 26, 2025)
Who to call at Jupiter Endovascular, and when
A new leader at Jupiter Endovascular brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Jupiter Endovascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Jupiter Endovascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Jupiter Endovascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Jupiter Endovascular changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Jupiter Endovascular changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.